Cargando…

One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study

Introduction: Debridement, antibiotics and implant retention (DAIR) procedures are effective treatments for acute postoperative or acute hematogenous periprosthetic joint infections. However, literature reporting on the effectiveness of DAIR procedures performed after a one- or two-stage revision be...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmohamed, F. Ruben H. A., van Dijk, Bruce, Veltman, Ewout S., Hoekstra, Marrit, Rentenaar, Rob J., Weinans, Harrie H., Vogely, H. Charles, van der Wal, Bart C. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Copernicus GmbH 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129908/
https://www.ncbi.nlm.nih.gov/pubmed/34084696
http://dx.doi.org/10.5194/jbji-6-91-2021
_version_ 1783694401464172544
author Nurmohamed, F. Ruben H. A.
van Dijk, Bruce
Veltman, Ewout S.
Hoekstra, Marrit
Rentenaar, Rob J.
Weinans, Harrie H.
Vogely, H. Charles
van der Wal, Bart C. H.
author_facet Nurmohamed, F. Ruben H. A.
van Dijk, Bruce
Veltman, Ewout S.
Hoekstra, Marrit
Rentenaar, Rob J.
Weinans, Harrie H.
Vogely, H. Charles
van der Wal, Bart C. H.
author_sort Nurmohamed, F. Ruben H. A.
collection PubMed
description Introduction: Debridement, antibiotics and implant retention (DAIR) procedures are effective treatments for acute postoperative or acute hematogenous periprosthetic joint infections. However, literature reporting on the effectiveness of DAIR procedures performed after a one- or two-stage revision because of a prosthetic joint infection (PJI) (PJI-related revision arthroplasty) is scarce. The aim of this study is to retrospectively evaluate the infection control after 1 year of a DAIR procedure in the case of an early postoperative infection either after primary arthroplasty or after PJI-related revision arthroplasty. Materials and methods: All patients treated with a DAIR procedure within 3 months after onset of PJI between 2009 and 2017 were retrospectively included. Data were collected on patient and infection characteristics. All infections were confirmed by applying the Musculoskeletal Infection Society (MSIS) 2014 criteria. The primary outcome was successful control of infection at 1 year after a DAIR procedure, which was defined as the absence of clinical signs, such as pain, swelling, and erythema; radiological signs, such as protheses loosening; or laboratory signs, such as C-reactive protein (CRP) ([Formula: see text]) with no use of antibiotic therapy. Results: Sixty-seven patients were treated with a DAIR procedure (41 hips and 26 knees). Successful infection control rates of a DAIR procedure after primary arthroplasty ([Formula: see text]) and after prior PJI-related revision arthroplasty ([Formula: see text]) were 69 % and 56 %, respectively ([Formula: see text]). The successful infection control rates of a DAIR procedure after an early acute infection ([Formula: see text]) and after a hematogenous infection ([Formula: see text]) following primary arthroplasty were both 69 % ([Formula: see text]). Conclusion: In this limited study population, no statistically significant difference is found in infection control after 1 year between DAIR procedures after primary arthroplasty and PJI-related revision arthroplasty.
format Online
Article
Text
id pubmed-8129908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Copernicus GmbH
record_format MEDLINE/PubMed
spelling pubmed-81299082021-06-02 One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study Nurmohamed, F. Ruben H. A. van Dijk, Bruce Veltman, Ewout S. Hoekstra, Marrit Rentenaar, Rob J. Weinans, Harrie H. Vogely, H. Charles van der Wal, Bart C. H. J Bone Jt Infect Original Full-Length Article Introduction: Debridement, antibiotics and implant retention (DAIR) procedures are effective treatments for acute postoperative or acute hematogenous periprosthetic joint infections. However, literature reporting on the effectiveness of DAIR procedures performed after a one- or two-stage revision because of a prosthetic joint infection (PJI) (PJI-related revision arthroplasty) is scarce. The aim of this study is to retrospectively evaluate the infection control after 1 year of a DAIR procedure in the case of an early postoperative infection either after primary arthroplasty or after PJI-related revision arthroplasty. Materials and methods: All patients treated with a DAIR procedure within 3 months after onset of PJI between 2009 and 2017 were retrospectively included. Data were collected on patient and infection characteristics. All infections were confirmed by applying the Musculoskeletal Infection Society (MSIS) 2014 criteria. The primary outcome was successful control of infection at 1 year after a DAIR procedure, which was defined as the absence of clinical signs, such as pain, swelling, and erythema; radiological signs, such as protheses loosening; or laboratory signs, such as C-reactive protein (CRP) ([Formula: see text]) with no use of antibiotic therapy. Results: Sixty-seven patients were treated with a DAIR procedure (41 hips and 26 knees). Successful infection control rates of a DAIR procedure after primary arthroplasty ([Formula: see text]) and after prior PJI-related revision arthroplasty ([Formula: see text]) were 69 % and 56 %, respectively ([Formula: see text]). The successful infection control rates of a DAIR procedure after an early acute infection ([Formula: see text]) and after a hematogenous infection ([Formula: see text]) following primary arthroplasty were both 69 % ([Formula: see text]). Conclusion: In this limited study population, no statistically significant difference is found in infection control after 1 year between DAIR procedures after primary arthroplasty and PJI-related revision arthroplasty. Copernicus GmbH 2021-01-27 /pmc/articles/PMC8129908/ /pubmed/34084696 http://dx.doi.org/10.5194/jbji-6-91-2021 Text en Copyright: © 2021 F. Ruben H. A. Nurmohamed et al. https://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
spellingShingle Original Full-Length Article
Nurmohamed, F. Ruben H. A.
van Dijk, Bruce
Veltman, Ewout S.
Hoekstra, Marrit
Rentenaar, Rob J.
Weinans, Harrie H.
Vogely, H. Charles
van der Wal, Bart C. H.
One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
title One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
title_full One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
title_fullStr One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
title_full_unstemmed One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
title_short One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
title_sort one-year infection control rates of a dair (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
topic Original Full-Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129908/
https://www.ncbi.nlm.nih.gov/pubmed/34084696
http://dx.doi.org/10.5194/jbji-6-91-2021
work_keys_str_mv AT nurmohamedfrubenha oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy
AT vandijkbruce oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy
AT veltmanewouts oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy
AT hoekstramarrit oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy
AT rentenaarrobj oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy
AT weinansharrieh oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy
AT vogelyhcharles oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy
AT vanderwalbartch oneyearinfectioncontrolratesofadairdebridementantibioticsandimplantretentionprocedureafterprimaryandprostheticjointinfectionrelatedrevisionarthroplastyaretrospectivecohortstudy